Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400113 · ClinicalTrials.gov registry record · Phase 4
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets
A Phase 4 study, sponsored by Unity Health Toronto.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT01400113 is a Phase 4 study that has completed, run by Unity Health Toronto. The registered enrollment target is 120 participants.
The verdict
NCT01400113, a Phase 4 study, has completed, sponsored by Unity Health Toronto.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
Our proposal is to administer asenapine to patients who are clinically agitated and in need of immediate intervention. At present there are no controlled studies that we know of that explores the use of asenapine for this purpose. Establishing the utility of asenapine for this common clinical problem will support its use as an additional treatment option in acutely agitated patients.
Interventions
- DRUG Placebo
- DRUG Asenapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400113
The ClinicalTrials.gov registry entry for NCT01400113 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Unity Health Toronto, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01400113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01400113 about?
NCT01400113 is a clinical study titled "Treating Acutely Agitated Patients With Asenapine Sublingual Tablets". Our proposal is to administer asenapine to patients who are clinically agitated and in need of immediate intervention. At present there are no controlled studies that we know of that explores the use of asenapine for this purpose. Establishing the utility of asenapine for this common clinical proble...
What is the current status of trial NCT01400113?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2012-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01400113?
The interventions under investigation include: Placebo (DRUG), Asenapine (DRUG).
Who is sponsoring clinical trial NCT01400113?
This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.